CAMP4 Therapeutics Corporation
USD3.98
-0.06 (-1.49%)
CEO
Joshua Mandel-Brehm
IPO Date
2024-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.99
Prev. Close
$4.04
Day Low
$3.90
Day High
$4.17
52W Low
$1.30
52W High
$7.75
Market Cap
$0.08B
Volume
0.09M
| 215,000 |
| $4.46 |
| 3 Apr 2026 | Gold Kelly | Chief Financial Officer | A-Award | Acquired | 215,000 | $4.46 |
| 3 Apr 2026 | Mandel-Brehm Josh | director, officer: Chief Executive Officer | A-Award | Acquired | 580,000 | $4.46 |
| 3 Apr 2026 | MacLean Michael F | director | A-Award | Acquired | 56,000 | $4.46 |
| 3 Apr 2026 | MacLean Michael F | director: | Disposed | 0 | $0.00 |
| 22 Dec 2025 | Tardiff Daniel | Chief Scientific Officer | A-Award | Acquired | 145,500 | $6.01 |
| 22 Dec 2025 | Maricich Yuri | Chief Medical Officer | A-Award | Acquired | 190,000 | $6.01 |
| 22 Dec 2025 | Gold Kelly | Chief Financial Officer | A-Award | Acquired | 190,000 | $6.01 |
| 22 Dec 2025 | Mandel-Brehm Josh | director, officer: Chief Executive Officer | A-Award | Acquired | 425,000 | $6.01 |